MBRX reverse split history: Moleculin Biotech, Inc.
Listed on Nasdaq. Split dates, ratios and the filings behind them.
On the reverse split lists now
- Stage lockedRatio not statedeffective Tue, Oct 20, 2026
Source: 8-K, filed Oct 20, 2026
Stage, approval route, meeting and approval dates are part of SplitScanner.
Unlock with SplitScannerSplit history
| Effective date | Direction | Ratio | Status |
|---|---|---|---|
| Oct 20, 2026 | Reverse | 1 to 20 | Took effect |
| Dec 1, 2025 | Reverse | 1 to 25 | Took effect |
| Mar 22, 2024 | Reverse | 1 to 15 | Took effect |
| Feb 1, 2021 | Reverse | 1 to 6 | Took effect |
Exchange listing context
- bid price deficiencyNASDAQfiled Sep 18, 2026
Listing Rule 5550(a)(2). Estimated compliance period ends Mar 17, 2027. Not marked resolved in the index.
SEC filing 000143774926030757 - equity deficiencyNASDAQfiled Nov 21, 2025
Listing Rule 5550(b)(1). Estimated compliance period ends Jan 5, 2026. Marked resolved on Nov 21, 2025.
SEC filing 000143774925036006
Exchange deficiency notices Signal8 detected in 8-K Item 3.01 filings. No notice listed means none was found in that index, not that the company is in compliance.
Approval timeline
Locked3 tracked episodes on record. Every filing and step from proposal to effective date.
Included with SplitScanner ($9.99 a month) and Signal8 Pro.
Unlock with SplitScannerHow it traded after each split
Locked4 executed reverse splits on record. The move over the 30 days after each one, on one split basis.
Included with SplitScanner ($9.99 a month) and Signal8 Pro.
Unlock with SplitScannerFloat before and after
Locked100 float samples on record. Float around each split, from the daily float record.
Included with SplitScanner ($9.99 a month) and Signal8 Pro.
Unlock with SplitScannerAI summaries of the filings
Locked3 analysed filing or releases on record. Plain-English readings of each filing and press release about the split, from the Signal8 analysis.
Included with SplitScanner ($9.99 a month) and Signal8 Pro.
Unlock with SplitScannerSplit dates and ratios come from the market split calendar and are cross-checked against a second source; a row only one source evidences is marked unconfirmed. Funds, ETFs and other non-equity securities are excluded. The index is keyed by ticker symbol, so a company that changed symbol between splits appears under each symbol.